1 / 25

Cervical cancer screening problems and barriers in Latvia

Cervical cancer screening problems and barriers in Latvia. Ilze Viberga MD, PhD Ludmila Engele MD, PhD. Cervical cancer prevalence in 1990-2005. Cervical cancer prevalence in 1999 – 2005. Prevalence in according to stages of cervical cancer in 1990 – 2005.

aminia
Download Presentation

Cervical cancer screening problems and barriers in Latvia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cervical cancer screening problems and barriers in Latvia Ilze Viberga MD, PhD Ludmila Engele MD, PhD

  2. Cervical cancer prevalencein 1990-2005

  3. Cervical cancer prevalence in 1999 – 2005

  4. Prevalence in according to stages of cervical cancer in 1990 – 2005

  5. Cervical cancer incidence and mortality

  6. Cervical cancer incidence per 100.000 women in 1990-2005

  7. Cervical cancer incidence in according to age in 1990 – 2005

  8. Cervical cancer mortality per 100.000 women in 1990-2005

  9. Cervical cancer incidence and mortality in age groups in 2005

  10. Cervical cancer in Latvia

  11. Cervical cancer five years life expectancy /survival– all stages

  12. Cervical cancer five years life expectancy – early and late stages

  13. Latvian female population in 2005

  14. Cervical cancer screening in Latvia • The regulation of Cabinet of Ministers Nr.1046, December 19, 2006 (initially – 2005), with the supplement No.5 ”Programme of the preventive examinations” contains the Paragraph No.2.4 ”Cancer screening” (corrected in according to the proposal after the ”round-table” meeting in September, 2006): • Taking the smear from cervix of uterus as a screening test of cervical cancer in women in age from 25 to 70 years one time per three years

  15. Screening results in 2005 and 2006 (two target populations: 20-34; 35-70)

  16. Cervical cancer screening problems and barriers in Latvia • Informational • Organizational • Professional • Financial • Geographical

  17. Informational • Population doesn’t know: • about this disease (mass media role: radio, regional news papers, TV!) • about the meaning of screening: the test is not treatment or a diagnostic tool if the person is a sick • the regulation and accessibility of the service regarding to this test • Professionals don’t know: • about the meaning of screening test • what to do exactly because no unified methodology and guidelines of action or screening programme • how is the regulation and accessibility and payment of the service regarding to this test (Ministry of Health very often changes terms and conditions)

  18. Organizational • No calculations about the professional medical resources/population – geographical disproportion • Cultural-historical situation in female heath care (Ob/Gyn) • Private/public service disproportion (HCISA) (486/34 Ob/Gyn and 1800/1356/30 GP) – accessibility to the screening test service!!! • No data exchange between laboratories and GP about the abnormal smear results • No unified clinical database regarding to the abnormal smear results

  19. Professional • No trained nurses and midwives for the taking of smear • No smear taking control • No bordered competencies between GP and Ob/Gyn regarding to the abnormal smear results management • No clinical guidelines for the management of woman with the abnormal smear findings within the screening programme • No unified clinical-laboratory database • No qualification and training criteria (minimal work load) for laboratory staff in the cervical screening programme • Leishman methodology for preparation, coloring and assessment of smear (instead of Papanicolau)

  20. Financial • Public/private gynecological service disproportion (historical-cultural background, geographical situation) • Existing financial regulation does not allow to cover expenses of the taking and assessment of smear in screening programme for private gynecology and GP practice • Majority of women have to pay themselves for the smear taking and assessment • Accessibility to the screening programme is limited

  21. Geographical • Infrastructure, logistics disproportion (rural population) • Limited professional medical resources (rural regions) • No geographical density assessment of female population to plan financial and human resources for the screening programme implementation

  22. Work groups • Cabinet of Ministers (12 persons; March – August) • To work out the coordinated model for collaboration among different sectors to implement the organized screening programme • To realize and find solution of the existing problems and barriers for the implementation of the organized screening programme • To promote accessibility of health care service Ministry of Health • To realize and find solution of the existing problems and barriers for the implementation of the organized screening programme • Practical ways of solution and implementation Mass media and non-governmental organizations - information

  23. Eurochip project • Technical report for the organized cervical cancer screening programme implementation in Latvia • Main tasks: • Analysis and evaluation of the current situation of cervical cancer screening in Latvia • Defining the existing obstacles for the implementation of the organized cervical cancer screening in Latvia • Making of the report with in-depth recommendations for a national promotion strategy of the population-based National Screening Programme of cervical cancer • Stage of data collection

  24. Thank you for your attention!

  25. LATVIA DISCUSSION • Problems of different lab methods

More Related